Age, median [IQR], years 56 [40-70] 67 [59-73] 1.03 (1.01 to 1.06) 0.002 0 Sex (male) 83 (40.1) 25 (59.5) 2.20 (1.12 to 4.38) 0.02 0 Underlying malignancy, n (%) 0 Hematological malignancy 138 (66.7) 31 (73.8) 1 Solid malignancy 69 (33.3) 11 (26.2) 0.71 (0.32 to 1.46) 0.4 Time since diagnosis, n (%) 1 Diagnosis 8 (3.9) 1 (2.4) 1 < 1 year 119 (57.8) 22 (52.4) 1.48 (0.25 to 28.13) 0.7 1 to 5 years 48 (23.3) 10 (23.8) 1.67 (0.26 to 32.69) 0.6 > 5 years 31 (15.0) 9 (21.4) 2.32 (0.35 to 46.03) 0.5 Chemotherapy line, median [IQR] 1 [1-2] 1 [1-2] 1.02 (0.81 to 1.27) 0.8 2 Evolution, n (%) 0 Newly diagnosed or Controlled 129 (62.3) 15 (35.7) 1 Progression 78 (37.7) 27 (64.3) 2.98 (1.51 to 6.07) 0.002 Poor performance status (>2), n (%) 16 (8.1) 14 (35.0) 6.09 (2.65 to 14.01) 0.00002 12 Palliative status, n (%) 18 (8.7) 14 (33.3) 5.25 (2.33 to 11.75) 0.00005 Cardiovascular disease, n (%) 51 (24.6) 18 (42.9) 2.29 (1.14 to 4.56) 0.02 0 Diabetes mellitus, n (%) 15 (7.2) 8 (19.0) 3.01 (1.14 to 7.51) 0.02 0 Long course steroids, n (%) 24 (11.6) 11 (26.2) 2.71 (1.17 to 5.99) 0.02 0 HIV infection, n (%) 9 (4.3) 2 (4.76) 1.10 (0.16 to 4.47) 0.9 0 Bone marrow transplant, n (%) 9 (4.3) 7 (16.7) 4.40 (1.49 to 12.59) 0.006 0 Immunosuppressive agent, n (%) 6 (2.9) 2 (4.8) 1.68 (0.24 to 7.57) 0.5 0 Days of fever before ED, median [IQR] 1 [1-2] 1 [1-2] 0.94 (0.71 to 1.20) 0.6 9 Previous oral antibiotics before ED, n (%) 67 (32.4) 12 (28.6) 0.84 (0.39 to 1.70) 0.6 0 Diarrhea, n (%) 38 (18.4) 11 (26.2) 1.58 (0.70 to 3.35) 0.2 0 Mucositis, n (%) 48 (23.2) 9 (21.4) 0.90 (0.38 to 1.95) 0.8 0 Clinical focus of infection in the ED, n (%) 119 (57.5) 32 (76.2) 2.37 (1.14 to 5.31) 0.03 0 Sepsis or shock, n (%) 19 (9.2) 24 (57.1) 13.19 (6.18 to 29.13) <0.00001 0 High shock-index (≥1), n (%) 65 (31.6) 27 (64.3) 3.90 (1.97 to 8.00) 0.0001 1 Oxygen saturation, median [IQR] 99 [98-100] 97 [97-99] 0.80 (0.69 to 0.91) 0.001 1 Inadequate ED antibiotics, n (%) 33 (15.9) 20 (47.6) 4.79 (2.35 to 9.81) 0.00002 0 Time to antibiotics in the ED, median [IQR], min 92 [48-150] 66 [30-135] 1.00 (1.00 to 1.00) 0.097 9 MASCC risk-index, median [IQR] 22 [21-24] 17 [11-21] 0.77 (0.71 to 0.84) <0.00001 0 ED emergency department, HIV human immunodeficiency virus, IQR interquartile range, ICU intensive care unit, MASCC Multinational Association of Supportive Care in Cancer
